P2X7 receptor acts as an efficient drug target in regulating bone metabolism system

Biomed Pharmacother. 2020 May:125:110010. doi: 10.1016/j.biopha.2020.110010. Epub 2020 Feb 25.

Abstract

Skeletal system is a highly dynamic system going through continuous resorption and reconstruction to maintain homeostasis, which is influenced by numerous factors. Once the balance is disrupted, various kinds of bone diseases may occur such as osteoporosis. It has been well known that ATP (adenosine triphosphate), an important signaling molecule, is important in maintaining the dynamic balance of bone matrix. ATP mainly functions through P2X receptors, a kind of ATP receptors expressed by various kinds of bone cells to regulate the whole network of skeleton system. Among P2X receptors, P2X7 plays a crucial role in bone since P2X7 is widely expressed by bone cells and the mutation of P2X7 receptor is associated with kinds of bone diseases. It's acknowledged that P2X7 acts as a potential therapeutic target for clinical treatment of bone-related diseases but further investigations are needed for the practical application. However, since P2X7 has a complicated effect in many aspects, the exact role of P2X7 in skeleton system is ambiguous. This review discusses the function of P2X7 in bone and other cells and their general effect on skeleton system, especially focusing on the possible clinical application for bone diseases.

Keywords: ATP; Bone metabolism diseases; Osteoblasts; Osteoclasts; P2X7 receptor.

Publication types

  • Review

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Bone Diseases / drug therapy*
  • Bone Diseases / physiopathology
  • Bone and Bones / drug effects*
  • Bone and Bones / metabolism
  • Humans
  • Osteoporosis / drug therapy
  • Osteoporosis / physiopathology
  • Receptors, Purinergic P2X7 / drug effects*
  • Receptors, Purinergic P2X7 / metabolism

Substances

  • Receptors, Purinergic P2X7
  • Adenosine Triphosphate